Croup Cough: Clinical Characteristics and Management
Croup cough is characterized by a distinctive barking or "seal-like" cough accompanied by inspiratory stridor, hoarseness, and varying degrees of respiratory distress, typically affecting children between 6 months and 6 years of age. 1, 2
Clinical Presentation
Characteristic Features
- Croup typically begins with upper respiratory infection symptoms including low-grade fever and coryza (runny nose), followed by the development of the characteristic barking cough 3
- The hallmark "barking seal" cough is distinctive and a key diagnostic feature 4
- Inspiratory stridor may be present, especially when the child is agitated or crying 1, 3
- Hoarseness is commonly present due to laryngeal inflammation 2
Timing and Progression
- Symptoms often worsen at night and may improve during the day 3
- In most children, symptoms subside quickly with resolution of the cough within two days 3
- Croup most commonly presents in late fall or early winter 1
Age Distribution
- Most commonly affects children between 6 months and 6 years of age 1, 2
- Recurrent croup (defined as two or more episodes per year) may indicate an underlying structural or inflammatory airway abnormality 5
Pathophysiology
- Croup involves inflammation and edema of the subglottic region of the larynx, trachea, and bronchi 5
- The narrowest part of a child's airway (subglottic region) becomes further narrowed by inflammation, leading to the characteristic symptoms 2
- Parainfluenza virus (types 1-3) is the most common causative agent 3
- Other viral causes include respiratory syncytial virus, influenza, and adenovirus 2
Differential Diagnosis
When evaluating a child with croup-like symptoms, it's important to consider other potentially serious conditions:
- Epiglottitis - characterized by rapid onset, toxic appearance, drooling, and inability to swallow 4
- Bacterial tracheitis - presents with high fever and toxic appearance 3
- Foreign body aspiration - sudden onset without prodromal symptoms 3
- Peritonsillar or retropharyngeal abscess - progressive dysphagia and neck pain 3
- Angioedema - may have associated urticaria or history of allergies 3
Management
Pharmacological Treatment
- A single dose of dexamethasone (0.15 to 0.60 mg/kg) is recommended for ALL patients with croup, including those with mild disease 3
- Oral administration is preferred, but intramuscular dexamethasone or nebulized budesonide are reasonable alternatives for children who cannot tolerate oral medication 2
- Nebulized epinephrine (racemic epinephrine) should be reserved for moderate to severe croup with significant respiratory distress 2, 3
- Children who receive nebulized epinephrine must be monitored for at least 2 hours after administration due to risk of rebound airway obstruction 1
Supportive Care
- Maintaining at least 50% relative humidity in the child's room is recommended, although evidence for humidification therapy is limited 1, 3
- Supplemental oxygen should be provided if there is evidence of hypoxemia 1
- Keep the child calm, as agitation can worsen symptoms 4
Indications for Hospital Admission
- Stridor at rest 4
- Evidence of exhaustion or respiratory distress 4
- Toxic appearance 4
- Inability to maintain adequate oral hydration 3
- Inadequate response to initial treatment 2
Prognosis
- Most cases of croup are mild and self-limiting 3
- Only 1-8% of patients with croup require hospital admission 3
- Less than 3% of admitted patients require intubation 3
- The cough typically resolves within 2 days in most children 3
Special Considerations
- Recurrent croup (≥2 episodes per year) warrants evaluation for underlying structural abnormalities or other conditions 5
- Simultaneous administration of corticosteroids and epinephrine reduces the rate of intubation in patients with severe croup and impending respiratory failure 2
- Early intervention with corticosteroids can reduce symptom severity and decrease rates of return visits, emergency department visits, and hospital admissions 2